Biora Therapeutics Inc. (NASDAQ: BIOR)
$0.72
+0.0115 ( +1.61% ) 70.2K
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.
Market Data
Open
$0.72
Previous close
$0.71
Volume
70.2K
Market cap
$26.22M
Day range
$0.70 - $0.73
52 week range
$0.48 - $4.10
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 72 | May 15, 2024 |
8-k | 8K-related | 13 | May 15, 2024 |
ars | Annual reports | 1 | Apr 24, 2024 |
def | Proxies and info statements | 11 | Apr 24, 2024 |
pre | Proxies and info statements | 11 | Apr 12, 2024 |
8-k | 8K-related | 17 | Apr 02, 2024 |
10-k | Annual reports | 109 | Apr 01, 2024 |
8-k | 8K-related | 13 | Mar 26, 2024 |
8-k | 8K-related | 21 | Mar 11, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |